Tikcro Technologies Ltd.

$0.11+0.00%(+$0.00)
TickerSpark Score
59/100
Mixed
100
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TIKRF research report →

52-Week Range24% of range
Low $0.05
Current $0.11
High $0.30

Companywww.tikcro.com

Tikcro Technologies Ltd. focuses on development of biotechnology project in Israel. It offers anti-cytotoxic T-lymphocyte-associated protein 4 for cancer immune treatment.

CEO
Aviv Boim
IPO
2000
HQ
Hadera, IL

Price Chart

-6.67% · this period
$0.30$0.20$0.11Feb 18Aug 22Feb 24

Valuation

Market Cap
$1.09M
P/E
-2.27
P/S
0.00
P/B
0.29
EV/EBITDA
7.44
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-12.00%
ROIC
-13.69%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-478,000 · 48.55%
EPS
$-0.05 · 48.51%
Op Income
$-513,000
FCF YoY
49.30%

Performance & Tape

52W High
$0.30
52W Low
$0.05
50D MA
$0.13
200D MA
$0.15
Beta
-1.76
Avg Volume
466

Get TickerSpark's AI analysis on TIKRF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Oct 18, 06BRONSON STEVEN Nbuy36,506
Aug 11, 06BRONSON STEVEN Nbuy65,969
Jul 14, 06BRONSON STEVEN Nbuy65,655
May 25, 06BRONSON STEVEN Nbuy184,813
Apr 25, 06BRONSON STEVEN Nbuy86,257
Apr 7, 06BRONSON STEVEN Nother0
Apr 7, 06BRONSON STEVEN Nother0

Our TIKRF Coverage

We haven't published any research on TIKRF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate TIKRF Report →

Similar Companies